Update from irritating news flash - 23.8.18
To recap - the irritating news flash covered the rise in a liver enzyme* - alanine transaminase or ALT - which put a spanner in the smoothly turning chemotherapy wheel. Normal levels are around 4-56 International Units; on 7.8.18 mine was 370; on 9.8.18 it was 430. Really bad is >1000. Amid general uncertainty, (my) bewilderment, lack of helpful suggestions for the culprit, the way forward was to wait for the ALT to go down and/or carry out a liver ultrasound. Waiting for it to go down involved more morning visits to UCH for blood taking - Monday 13 August generated a result on Tuesday 15 August of 291 - in the right direction, if a long way from normal. On the phone, the registrar said that this was OK for chemo to go ahead on Friday (17 August - one week's delay) but without the bevacizumab (Avastin). This suggested that their best bet was that the bevacizumab was the cause, trigger, partner in crime when put together with chemo, whatever - but they certainly weren't ...